Kindstar Globalgene Technology, Inc. (09960.HK)株価、チャート、ニュース、およびAI分析

Q: Kindstar Globalgene Technology, Inc. のCEOは誰ですか？

Dr. Shiang Huang は Kindstar Globalgene Technology, Inc. の Executive Chairman of the Board で、2003 から在籍しています。

Q: KINDSTAR GLOBAL の株価パフォーマンスは？

KINDSTAR GLOBAL の現在の価格は $1.22 で、最終取引日から 0.81% 減少 変動しました。

Q: Kindstar Globalgene Technology, Inc. の主な事業テーマや業界は？

Kindstar Globalgene Technology, Inc. は Health Care 業界、セクターは Health Care に属しています。

Q: Kindstar Globalgene Technology, Inc. の時価総額はいくらですか？

Kindstar Globalgene Technology, Inc. の現在の時価総額は $1.2B です。

ホーム

株式

09960.HK

KINDSTAR GLOBAL (09960.HK)

Kindstar Globalgene Technology, Inc.

HK$1.22

-0.81%

$-0.01

休場: Jan 16, 16:00:00 HKT

主要データ

前終値

$1.21

始値

$1.23

当日レンジ

$1.2 - $1.24

52週レンジ

$1.05 - $1.75

取引高

1.9M

平均取引高

789.1K

1株当たり利益(TTM)

-0.12

配当利回り

時価総額

$1.2B

KINDSTAR GLOBALとは何ですか？

Kindstar Globalgene Technology, Inc. is an investment holding company, which engages in the provision of clinical testing services. The company is headquartered in Wuhan, Hubei and currently employs 3,162 full-time employees. The company went IPO on 2021-07-16. The firm includes nine segments. The Hematology Testing segment includes testing services related to blood diseases. The Genetic Diseases and Rare Diseases segment includes testing services from the rare disease. The Infectious Diseases segment includes testing services from the infection department. The Oncology segment includes testing related to oncology diseases. The Neurology segment includes testing services related to neurological diseases. The Maternity-Related Diseases segment includes testing services related to maternity. The Routine Testing segment conducts routine tests for the doctors’ daily diagnoses. The Scientific Research Services and Cro segment includes research and development services. The Others segment provides other miscellaneous testing services.

特徴

取引戦略